Dr. Mikhail Blagosklonny: Cancer And Aging Researcher, Educator And Scientist

Dr. Mikhail Blagosklonny is a researcher, educator and scientist. His areas of specialization are cancer and aging. He is also an oncologist with research interests that include cancer, targeted cancer therapies, the mechanisms that underlie aging, as well as anti-aging drugs. Dr. Blagosklonny is also an oncology professor. He teaches at Roswell Park Cancer Institute located in New York. He has also published in excess of 270 papers. His work is well respected and draws a great deal of interest in the peer-reviewed publications in which it appears. He has over 25,000 citations and an 83 h-index. View Mikhail’s profile in LinkedIn

Blagosklonny was educated at the First Pavlov State Medical University in St. Petersburg, Russia. During his time there he earned two degrees. He earned an M.D. in internal medicine as well as a PhD in cardiology and experimental medicine. In 2002 Mikhail Blagosklonny was hired at New York Medical College in Valhalla, New York as an associate professor of medicine. After that he became an Ordway Research Institute senior scientist. He remained in that position until 2009. At that point he moved on to Roswell Park Cancer Institute where he became a professor of oncology.

Mikhail Blogosklonny has done a great deal of work on cancer and aging. Based on his research he has formulated a unique hypothesis. He holds that TOR signaling may play a role in aging and cancer. Dr. Blagosklonny has proposed using the popular cancer drug rapamycin as one possible life extension treatment. He is known internationally as being among the most passionate advocates relative to the use of rapamycin in longevity research. Dr. Blagosklonny is the editor-in-chief of Oncotarget, Aging and Cell Cycle. He’s also Cancer Biology & Therapy’s associate editor and is on the Cell Death & Differentiation editorial board.

Dr. Blagosklonny has done in depth research on cancer therapies that have shown the potential to protect normal cells from being damaged during cancer treatment. His longevity research has yielded a great deal of valuable information that has led to a new way of looking at the way the body ages and the mechanisms that are involved in it. Follow Mikhail on Google Scholar.